Global Biologic Drugs Market Insight and Forecast to 2026
The research team projects that the Biologic Drugs market size will grow from XXX in 2019 to XXX by 2026, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size is projected from 2020 to 2026.
The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing with 10 major regions and 30 major countries. Deep researches and analysis were done during the preparation of the report. The readers will find this report very helpful in understanding the market in depth. The data and the information regarding the market are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the industry experts. The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and also helps in understanding the facts much better.
By Market Players:
Roche
Novartis
Merck & Co.
Abbott Laboratories
Sanofi
Johnson & Johnson
Amgen
Amgen
Pfizer
Eli Lilly
By Type
Humira
Remicade
Rituxan
Enbrel
Lantus
Avastin
Herceptin
Others
By Application
Diabetes
Inflammation
Auto-Immune Diseases
Blood Diseases
Cardiovascular Diseases
Others
By Regions/Countries:
North America
United States
Canada
Mexico
East Asia
China
Japan
South Korea
Europe
Germany
United Kingdom
France
Italy
South Asia
India
Southeast Asia
Indonesia
Thailand
Singapore
Middle East
Turkey
Saudi Arabia
Iran
Africa
Nigeria
South Africa
Oceania
Australia
South America
Points Covered in The Report
The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
The report focuses on Global, Top 10 Regions and Top 50 Countries Market Size of Biologic Drugs 2015-2020, and development forecast 2021-2026 including industries, major players/suppliers worldwide and market share by regions, with company and product introduction, position in the market including their market status and development trend by types and applications which will provide its price and profit status, and marketing status & market growth drivers and challenges, with base year as 2019.
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2015-2020 & Sales by Product Types.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2021-2026. Further the report provides break down details about each region & countries covered in the report. Identifying its production, consumption, import & export, sales volume & revenue forecast.
Market Analysis by Product Type: The report covers majority Product Types in the Biologic Drugs Industry, including its product specifications by each key player, volume, sales by Volume and Value (M USD).
Market Analysis by Application Type: Based on the Biologic Drugs Industry and its applications, the market is further sub-segmented into several major Application of its industry. It provides you with the market size, CAGR & forecast by each industry applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report will provide with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
COVID-19 Impact
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Biologic Drugs market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing with 10 major regions and 30 major countries. Deep researches and analysis were done during the preparation of the report. The readers will find this report very helpful in understanding the market in depth. The data and the information regarding the market are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the industry experts. The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and also helps in understanding the facts much better.
By Market Players:
Roche
Novartis
Merck & Co.
Abbott Laboratories
Sanofi
Johnson & Johnson
Amgen
Amgen
Pfizer
Eli Lilly
By Type
Humira
Remicade
Rituxan
Enbrel
Lantus
Avastin
Herceptin
Others
By Application
Diabetes
Inflammation
Auto-Immune Diseases
Blood Diseases
Cardiovascular Diseases
Others
By Regions/Countries:
North America
United States
Canada
Mexico
East Asia
China
Japan
South Korea
Europe
Germany
United Kingdom
France
Italy
South Asia
India
Southeast Asia
Indonesia
Thailand
Singapore
Middle East
Turkey
Saudi Arabia
Iran
Africa
Nigeria
South Africa
Oceania
Australia
South America
Points Covered in The Report
The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
The report focuses on Global, Top 10 Regions and Top 50 Countries Market Size of Biologic Drugs 2015-2020, and development forecast 2021-2026 including industries, major players/suppliers worldwide and market share by regions, with company and product introduction, position in the market including their market status and development trend by types and applications which will provide its price and profit status, and marketing status & market growth drivers and challenges, with base year as 2019.
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2015-2020 & Sales by Product Types.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2021-2026. Further the report provides break down details about each region & countries covered in the report. Identifying its production, consumption, import & export, sales volume & revenue forecast.
Market Analysis by Product Type: The report covers majority Product Types in the Biologic Drugs Industry, including its product specifications by each key player, volume, sales by Volume and Value (M USD).
Market Analysis by Application Type: Based on the Biologic Drugs Industry and its applications, the market is further sub-segmented into several major Application of its industry. It provides you with the market size, CAGR & forecast by each industry applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report will provide with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
COVID-19 Impact
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Biologic Drugs market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Biologic Drugs Revenue
1.4 Market Analysis by Type
1.4.1 Global Biologic Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Humira
1.4.3 Remicade
1.4.4 Rituxan
1.4.5 Enbrel
1.4.6 Lantus
1.4.7 Avastin
1.4.8 Herceptin
1.4.9 Others
1.5 Market by Application
1.5.1 Global Biologic Drugs Market Share by Application: 2021-2026
1.5.2 Diabetes
1.5.3 Inflammation
1.5.4 Auto-Immune Diseases
1.5.5 Blood Diseases
1.5.6 Cardiovascular Diseases
1.5.7 Others
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Biologic Drugs Market Perspective (2021-2026)
2.2 Biologic Drugs Growth Trends by Regions
2.2.1 Biologic Drugs Market Size by Regions: 2015 VS 2021 VS 2026
2.2.2 Biologic Drugs Historic Market Size by Regions (2015-2020)
2.2.3 Biologic Drugs Forecasted Market Size by Regions (2021-2026)
3 MARKET COMPETITION BY MANUFACTURERS
3.1 Global Biologic Drugs Production Capacity Market Share by Manufacturers (2015-2020)
3.2 Global Biologic Drugs Revenue Market Share by Manufacturers (2015-2020)
3.3 Global Biologic Drugs Average Price by Manufacturers (2015-2020)
4 BIOLOGIC DRUGS PRODUCTION BY REGIONS
4.1 North America
4.1.1 North America Biologic Drugs Market Size (2015-2026)
4.1.2 Biologic Drugs Key Players in North America (2015-2020)
4.1.3 North America Biologic Drugs Market Size by Type (2015-2020)
4.1.4 North America Biologic Drugs Market Size by Application (2015-2020)
4.2 East Asia
4.2.1 East Asia Biologic Drugs Market Size (2015-2026)
4.2.2 Biologic Drugs Key Players in East Asia (2015-2020)
4.2.3 East Asia Biologic Drugs Market Size by Type (2015-2020)
4.2.4 East Asia Biologic Drugs Market Size by Application (2015-2020)
4.3 Europe
4.3.1 Europe Biologic Drugs Market Size (2015-2026)
4.3.2 Biologic Drugs Key Players in Europe (2015-2020)
4.3.3 Europe Biologic Drugs Market Size by Type (2015-2020)
4.3.4 Europe Biologic Drugs Market Size by Application (2015-2020)
4.4 South Asia
4.4.1 South Asia Biologic Drugs Market Size (2015-2026)
4.4.2 Biologic Drugs Key Players in South Asia (2015-2020)
4.4.3 South Asia Biologic Drugs Market Size by Type (2015-2020)
4.4.4 South Asia Biologic Drugs Market Size by Application (2015-2020)
4.5 Southeast Asia
4.5.1 Southeast Asia Biologic Drugs Market Size (2015-2026)
4.5.2 Biologic Drugs Key Players in Southeast Asia (2015-2020)
4.5.3 Southeast Asia Biologic Drugs Market Size by Type (2015-2020)
4.5.4 Southeast Asia Biologic Drugs Market Size by Application (2015-2020)
4.6 Middle East
4.6.1 Middle East Biologic Drugs Market Size (2015-2026)
4.6.2 Biologic Drugs Key Players in Middle East (2015-2020)
4.6.3 Middle East Biologic Drugs Market Size by Type (2015-2020)
4.6.4 Middle East Biologic Drugs Market Size by Application (2015-2020)
4.7 Africa
4.7.1 Africa Biologic Drugs Market Size (2015-2026)
4.7.2 Biologic Drugs Key Players in Africa (2015-2020)
4.7.3 Africa Biologic Drugs Market Size by Type (2015-2020)
4.7.4 Africa Biologic Drugs Market Size by Application (2015-2020)
4.8 Oceania
4.8.1 Oceania Biologic Drugs Market Size (2015-2026)
4.8.2 Biologic Drugs Key Players in Oceania (2015-2020)
4.8.3 Oceania Biologic Drugs Market Size by Type (2015-2020)
4.8.4 Oceania Biologic Drugs Market Size by Application (2015-2020)
4.9 South America
4.9.1 South America Biologic Drugs Market Size (2015-2026)
4.9.2 Biologic Drugs Key Players in South America (2015-2020)
4.9.3 South America Biologic Drugs Market Size by Type (2015-2020)
4.9.4 South America Biologic Drugs Market Size by Application (2015-2020)
4.10 Rest of the World
4.10.1 Rest of the World Biologic Drugs Market Size (2015-2026)
4.10.2 Biologic Drugs Key Players in Rest of the World (2015-2020)
4.10.3 Rest of the World Biologic Drugs Market Size by Type (2015-2020)
4.10.4 Rest of the World Biologic Drugs Market Size by Application (2015-2020)
5 BIOLOGIC DRUGS CONSUMPTION BY REGION
5.1 North America
5.1.1 North America Biologic Drugs Consumption by Countries
5.1.2 United States
5.1.3 Canada
5.1.4 Mexico
5.2 East Asia
5.2.1 East Asia Biologic Drugs Consumption by Countries
5.2.2 China
5.2.3 Japan
5.2.4 South Korea
5.3 Europe
5.3.1 Europe Biologic Drugs Consumption by Countries
5.3.2 Germany
5.3.3 United Kingdom
5.3.4 France
5.3.5 Italy
5.3.6 Russia
5.3.7 Spain
5.3.8 Netherlands
5.3.9 Switzerland
5.3.10 Poland
5.4 South Asia
5.4.1 South Asia Biologic Drugs Consumption by Countries
5.4.2 India
5.4.3 Pakistan
5.4.4 Bangladesh
5.5 Southeast Asia
5.5.1 Southeast Asia Biologic Drugs Consumption by Countries
5.5.2 Indonesia
5.5.3 Thailand
5.5.4 Singapore
5.5.5 Malaysia
5.5.6 Philippines
5.5.7 Vietnam
5.5.8 Myanmar
5.6 Middle East
5.6.1 Middle East Biologic Drugs Consumption by Countries
5.6.2 Turkey
5.6.3 Saudi Arabia
5.6.4 Iran
5.6.5 United Arab Emirates
5.6.6 Israel
5.6.7 Iraq
5.6.8 Qatar
5.6.9 Kuwait
5.6.10 Oman
5.7 Africa
5.7.1 Africa Biologic Drugs Consumption by Countries
5.7.2 Nigeria
5.7.3 South Africa
5.7.4 Egypt
5.7.5 Algeria
5.7.6 Morocco
5.8 Oceania
5.8.1 Oceania Biologic Drugs Consumption by Countries
5.8.2 Australia
5.8.3 New Zealand
5.9 South America
5.9.1 South America Biologic Drugs Consumption by Countries
5.9.2 Brazil
5.9.3 Argentina
5.9.4 Columbia
5.9.5 Chile
5.9.6 Venezuela
5.9.7 Peru
5.9.8 Puerto Rico
5.9.9 Ecuador
5.10 Rest of the World
5.10.1 Rest of the World Biologic Drugs Consumption by Countries
5.10.2 Kazakhstan
6 BIOLOGIC DRUGS SALES MARKET BY TYPE (2015-2026)
6.1 Global Biologic Drugs Historic Market Size by Type (2015-2020)
6.2 Global Biologic Drugs Forecasted Market Size by Type (2021-2026)
7 BIOLOGIC DRUGS CONSUMPTION MARKET BY APPLICATION(2015-2026)
7.1 Global Biologic Drugs Historic Market Size by Application (2015-2020)
7.2 Global Biologic Drugs Forecasted Market Size by Application (2021-2026)
8 COMPANY PROFILES AND KEY FIGURES IN BIOLOGIC DRUGS BUSINESS
8.1 Roche
8.1.1 Roche Company Profile
8.1.2 Roche Biologic Drugs Product Specification
8.1.3 Roche Biologic Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.2 Novartis
8.2.1 Novartis Company Profile
8.2.2 Novartis Biologic Drugs Product Specification
8.2.3 Novartis Biologic Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.3 Merck & Co.
8.3.1 Merck & Co. Company Profile
8.3.2 Merck & Co. Biologic Drugs Product Specification
8.3.3 Merck & Co. Biologic Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.4 Abbott Laboratories
8.4.1 Abbott Laboratories Company Profile
8.4.2 Abbott Laboratories Biologic Drugs Product Specification
8.4.3 Abbott Laboratories Biologic Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.5 Sanofi
8.5.1 Sanofi Company Profile
8.5.2 Sanofi Biologic Drugs Product Specification
8.5.3 Sanofi Biologic Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.6 Johnson & Johnson
8.6.1 Johnson & Johnson Company Profile
8.6.2 Johnson & Johnson Biologic Drugs Product Specification
8.6.3 Johnson & Johnson Biologic Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.7 Amgen
8.7.1 Amgen Company Profile
8.7.2 Amgen Biologic Drugs Product Specification
8.7.3 Amgen Biologic Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.8 Amgen
8.8.1 Amgen Company Profile
8.8.2 Amgen Biologic Drugs Product Specification
8.8.3 Amgen Biologic Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.9 Pfizer
8.9.1 Pfizer Company Profile
8.9.2 Pfizer Biologic Drugs Product Specification
8.9.3 Pfizer Biologic Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.10 Eli Lilly
8.10.1 Eli Lilly Company Profile
8.10.2 Eli Lilly Biologic Drugs Product Specification
8.10.3 Eli Lilly Biologic Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
9 PRODUCTION AND SUPPLY FORECAST
9.1 Global Forecasted Production of Biologic Drugs (2021-2026)
9.2 Global Forecasted Revenue of Biologic Drugs (2021-2026)
9.3 Global Forecasted Price of Biologic Drugs (2015-2026)
9.4 Global Forecasted Production of Biologic Drugs by Region (2021-2026)
9.4.1 North America Biologic Drugs Production, Revenue Forecast (2021-2026)
9.4.2 East Asia Biologic Drugs Production, Revenue Forecast (2021-2026)
9.4.3 Europe Biologic Drugs Production, Revenue Forecast (2021-2026)
9.4.4 South Asia Biologic Drugs Production, Revenue Forecast (2021-2026)
9.4.5 Southeast Asia Biologic Drugs Production, Revenue Forecast (2021-2026)
9.4.6 Middle East Biologic Drugs Production, Revenue Forecast (2021-2026)
9.4.7 Africa Biologic Drugs Production, Revenue Forecast (2021-2026)
9.4.8 Oceania Biologic Drugs Production, Revenue Forecast (2021-2026)
9.4.9 South America Biologic Drugs Production, Revenue Forecast (2021-2026)
9.4.10 Rest of the World Biologic Drugs Production, Revenue Forecast (2021-2026)
9.5 Forecast by Type and by Application (2021-2026)
9.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
9.5.2 Global Forecasted Consumption of Biologic Drugs by Application (2021-2026)
10 CONSUMPTION AND DEMAND FORECAST
10.1 North America Forecasted Consumption of Biologic Drugs by Country
10.2 East Asia Market Forecasted Consumption of Biologic Drugs by Country
10.3 Europe Market Forecasted Consumption of Biologic Drugs by Countriy
10.4 South Asia Forecasted Consumption of Biologic Drugs by Country
10.5 Southeast Asia Forecasted Consumption of Biologic Drugs by Country
10.6 Middle East Forecasted Consumption of Biologic Drugs by Country
10.7 Africa Forecasted Consumption of Biologic Drugs by Country
10.8 Oceania Forecasted Consumption of Biologic Drugs by Country
10.9 South America Forecasted Consumption of Biologic Drugs by Country
10.10 Rest of the world Forecasted Consumption of Biologic Drugs by Country
11 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
11.1 Marketing Channel
11.2 Biologic Drugs Distributors List
11.3 Biologic Drugs Customers
12 INDUSTRY TRENDS AND GROWTH STRATEGY
12.1 Market Top Trends
12.2 Market Drivers
12.3 Market Challenges
12.4 Porter’s Five Forces Analysis
12.5 Biologic Drugs Market Growth Strategy
13 ANALYST'S VIEWPOINTS/CONCLUSIONS
14 APPENDIX
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Disclaimer
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Biologic Drugs Revenue
1.4 Market Analysis by Type
1.4.1 Global Biologic Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Humira
1.4.3 Remicade
1.4.4 Rituxan
1.4.5 Enbrel
1.4.6 Lantus
1.4.7 Avastin
1.4.8 Herceptin
1.4.9 Others
1.5 Market by Application
1.5.1 Global Biologic Drugs Market Share by Application: 2021-2026
1.5.2 Diabetes
1.5.3 Inflammation
1.5.4 Auto-Immune Diseases
1.5.5 Blood Diseases
1.5.6 Cardiovascular Diseases
1.5.7 Others
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Biologic Drugs Market Perspective (2021-2026)
2.2 Biologic Drugs Growth Trends by Regions
2.2.1 Biologic Drugs Market Size by Regions: 2015 VS 2021 VS 2026
2.2.2 Biologic Drugs Historic Market Size by Regions (2015-2020)
2.2.3 Biologic Drugs Forecasted Market Size by Regions (2021-2026)
3 MARKET COMPETITION BY MANUFACTURERS
3.1 Global Biologic Drugs Production Capacity Market Share by Manufacturers (2015-2020)
3.2 Global Biologic Drugs Revenue Market Share by Manufacturers (2015-2020)
3.3 Global Biologic Drugs Average Price by Manufacturers (2015-2020)
4 BIOLOGIC DRUGS PRODUCTION BY REGIONS
4.1 North America
4.1.1 North America Biologic Drugs Market Size (2015-2026)
4.1.2 Biologic Drugs Key Players in North America (2015-2020)
4.1.3 North America Biologic Drugs Market Size by Type (2015-2020)
4.1.4 North America Biologic Drugs Market Size by Application (2015-2020)
4.2 East Asia
4.2.1 East Asia Biologic Drugs Market Size (2015-2026)
4.2.2 Biologic Drugs Key Players in East Asia (2015-2020)
4.2.3 East Asia Biologic Drugs Market Size by Type (2015-2020)
4.2.4 East Asia Biologic Drugs Market Size by Application (2015-2020)
4.3 Europe
4.3.1 Europe Biologic Drugs Market Size (2015-2026)
4.3.2 Biologic Drugs Key Players in Europe (2015-2020)
4.3.3 Europe Biologic Drugs Market Size by Type (2015-2020)
4.3.4 Europe Biologic Drugs Market Size by Application (2015-2020)
4.4 South Asia
4.4.1 South Asia Biologic Drugs Market Size (2015-2026)
4.4.2 Biologic Drugs Key Players in South Asia (2015-2020)
4.4.3 South Asia Biologic Drugs Market Size by Type (2015-2020)
4.4.4 South Asia Biologic Drugs Market Size by Application (2015-2020)
4.5 Southeast Asia
4.5.1 Southeast Asia Biologic Drugs Market Size (2015-2026)
4.5.2 Biologic Drugs Key Players in Southeast Asia (2015-2020)
4.5.3 Southeast Asia Biologic Drugs Market Size by Type (2015-2020)
4.5.4 Southeast Asia Biologic Drugs Market Size by Application (2015-2020)
4.6 Middle East
4.6.1 Middle East Biologic Drugs Market Size (2015-2026)
4.6.2 Biologic Drugs Key Players in Middle East (2015-2020)
4.6.3 Middle East Biologic Drugs Market Size by Type (2015-2020)
4.6.4 Middle East Biologic Drugs Market Size by Application (2015-2020)
4.7 Africa
4.7.1 Africa Biologic Drugs Market Size (2015-2026)
4.7.2 Biologic Drugs Key Players in Africa (2015-2020)
4.7.3 Africa Biologic Drugs Market Size by Type (2015-2020)
4.7.4 Africa Biologic Drugs Market Size by Application (2015-2020)
4.8 Oceania
4.8.1 Oceania Biologic Drugs Market Size (2015-2026)
4.8.2 Biologic Drugs Key Players in Oceania (2015-2020)
4.8.3 Oceania Biologic Drugs Market Size by Type (2015-2020)
4.8.4 Oceania Biologic Drugs Market Size by Application (2015-2020)
4.9 South America
4.9.1 South America Biologic Drugs Market Size (2015-2026)
4.9.2 Biologic Drugs Key Players in South America (2015-2020)
4.9.3 South America Biologic Drugs Market Size by Type (2015-2020)
4.9.4 South America Biologic Drugs Market Size by Application (2015-2020)
4.10 Rest of the World
4.10.1 Rest of the World Biologic Drugs Market Size (2015-2026)
4.10.2 Biologic Drugs Key Players in Rest of the World (2015-2020)
4.10.3 Rest of the World Biologic Drugs Market Size by Type (2015-2020)
4.10.4 Rest of the World Biologic Drugs Market Size by Application (2015-2020)
5 BIOLOGIC DRUGS CONSUMPTION BY REGION
5.1 North America
5.1.1 North America Biologic Drugs Consumption by Countries
5.1.2 United States
5.1.3 Canada
5.1.4 Mexico
5.2 East Asia
5.2.1 East Asia Biologic Drugs Consumption by Countries
5.2.2 China
5.2.3 Japan
5.2.4 South Korea
5.3 Europe
5.3.1 Europe Biologic Drugs Consumption by Countries
5.3.2 Germany
5.3.3 United Kingdom
5.3.4 France
5.3.5 Italy
5.3.6 Russia
5.3.7 Spain
5.3.8 Netherlands
5.3.9 Switzerland
5.3.10 Poland
5.4 South Asia
5.4.1 South Asia Biologic Drugs Consumption by Countries
5.4.2 India
5.4.3 Pakistan
5.4.4 Bangladesh
5.5 Southeast Asia
5.5.1 Southeast Asia Biologic Drugs Consumption by Countries
5.5.2 Indonesia
5.5.3 Thailand
5.5.4 Singapore
5.5.5 Malaysia
5.5.6 Philippines
5.5.7 Vietnam
5.5.8 Myanmar
5.6 Middle East
5.6.1 Middle East Biologic Drugs Consumption by Countries
5.6.2 Turkey
5.6.3 Saudi Arabia
5.6.4 Iran
5.6.5 United Arab Emirates
5.6.6 Israel
5.6.7 Iraq
5.6.8 Qatar
5.6.9 Kuwait
5.6.10 Oman
5.7 Africa
5.7.1 Africa Biologic Drugs Consumption by Countries
5.7.2 Nigeria
5.7.3 South Africa
5.7.4 Egypt
5.7.5 Algeria
5.7.6 Morocco
5.8 Oceania
5.8.1 Oceania Biologic Drugs Consumption by Countries
5.8.2 Australia
5.8.3 New Zealand
5.9 South America
5.9.1 South America Biologic Drugs Consumption by Countries
5.9.2 Brazil
5.9.3 Argentina
5.9.4 Columbia
5.9.5 Chile
5.9.6 Venezuela
5.9.7 Peru
5.9.8 Puerto Rico
5.9.9 Ecuador
5.10 Rest of the World
5.10.1 Rest of the World Biologic Drugs Consumption by Countries
5.10.2 Kazakhstan
6 BIOLOGIC DRUGS SALES MARKET BY TYPE (2015-2026)
6.1 Global Biologic Drugs Historic Market Size by Type (2015-2020)
6.2 Global Biologic Drugs Forecasted Market Size by Type (2021-2026)
7 BIOLOGIC DRUGS CONSUMPTION MARKET BY APPLICATION(2015-2026)
7.1 Global Biologic Drugs Historic Market Size by Application (2015-2020)
7.2 Global Biologic Drugs Forecasted Market Size by Application (2021-2026)
8 COMPANY PROFILES AND KEY FIGURES IN BIOLOGIC DRUGS BUSINESS
8.1 Roche
8.1.1 Roche Company Profile
8.1.2 Roche Biologic Drugs Product Specification
8.1.3 Roche Biologic Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.2 Novartis
8.2.1 Novartis Company Profile
8.2.2 Novartis Biologic Drugs Product Specification
8.2.3 Novartis Biologic Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.3 Merck & Co.
8.3.1 Merck & Co. Company Profile
8.3.2 Merck & Co. Biologic Drugs Product Specification
8.3.3 Merck & Co. Biologic Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.4 Abbott Laboratories
8.4.1 Abbott Laboratories Company Profile
8.4.2 Abbott Laboratories Biologic Drugs Product Specification
8.4.3 Abbott Laboratories Biologic Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.5 Sanofi
8.5.1 Sanofi Company Profile
8.5.2 Sanofi Biologic Drugs Product Specification
8.5.3 Sanofi Biologic Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.6 Johnson & Johnson
8.6.1 Johnson & Johnson Company Profile
8.6.2 Johnson & Johnson Biologic Drugs Product Specification
8.6.3 Johnson & Johnson Biologic Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.7 Amgen
8.7.1 Amgen Company Profile
8.7.2 Amgen Biologic Drugs Product Specification
8.7.3 Amgen Biologic Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.8 Amgen
8.8.1 Amgen Company Profile
8.8.2 Amgen Biologic Drugs Product Specification
8.8.3 Amgen Biologic Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.9 Pfizer
8.9.1 Pfizer Company Profile
8.9.2 Pfizer Biologic Drugs Product Specification
8.9.3 Pfizer Biologic Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.10 Eli Lilly
8.10.1 Eli Lilly Company Profile
8.10.2 Eli Lilly Biologic Drugs Product Specification
8.10.3 Eli Lilly Biologic Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
9 PRODUCTION AND SUPPLY FORECAST
9.1 Global Forecasted Production of Biologic Drugs (2021-2026)
9.2 Global Forecasted Revenue of Biologic Drugs (2021-2026)
9.3 Global Forecasted Price of Biologic Drugs (2015-2026)
9.4 Global Forecasted Production of Biologic Drugs by Region (2021-2026)
9.4.1 North America Biologic Drugs Production, Revenue Forecast (2021-2026)
9.4.2 East Asia Biologic Drugs Production, Revenue Forecast (2021-2026)
9.4.3 Europe Biologic Drugs Production, Revenue Forecast (2021-2026)
9.4.4 South Asia Biologic Drugs Production, Revenue Forecast (2021-2026)
9.4.5 Southeast Asia Biologic Drugs Production, Revenue Forecast (2021-2026)
9.4.6 Middle East Biologic Drugs Production, Revenue Forecast (2021-2026)
9.4.7 Africa Biologic Drugs Production, Revenue Forecast (2021-2026)
9.4.8 Oceania Biologic Drugs Production, Revenue Forecast (2021-2026)
9.4.9 South America Biologic Drugs Production, Revenue Forecast (2021-2026)
9.4.10 Rest of the World Biologic Drugs Production, Revenue Forecast (2021-2026)
9.5 Forecast by Type and by Application (2021-2026)
9.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
9.5.2 Global Forecasted Consumption of Biologic Drugs by Application (2021-2026)
10 CONSUMPTION AND DEMAND FORECAST
10.1 North America Forecasted Consumption of Biologic Drugs by Country
10.2 East Asia Market Forecasted Consumption of Biologic Drugs by Country
10.3 Europe Market Forecasted Consumption of Biologic Drugs by Countriy
10.4 South Asia Forecasted Consumption of Biologic Drugs by Country
10.5 Southeast Asia Forecasted Consumption of Biologic Drugs by Country
10.6 Middle East Forecasted Consumption of Biologic Drugs by Country
10.7 Africa Forecasted Consumption of Biologic Drugs by Country
10.8 Oceania Forecasted Consumption of Biologic Drugs by Country
10.9 South America Forecasted Consumption of Biologic Drugs by Country
10.10 Rest of the world Forecasted Consumption of Biologic Drugs by Country
11 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
11.1 Marketing Channel
11.2 Biologic Drugs Distributors List
11.3 Biologic Drugs Customers
12 INDUSTRY TRENDS AND GROWTH STRATEGY
12.1 Market Top Trends
12.2 Market Drivers
12.3 Market Challenges
12.4 Porter’s Five Forces Analysis
12.5 Biologic Drugs Market Growth Strategy
13 ANALYST'S VIEWPOINTS/CONCLUSIONS
14 APPENDIX
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Disclaimer
LIST OF TABLES AND FIGURES
Table 1. Global Biologic Drugs Market Share by Type: 2020 VS 2026
Table 2. Humira Features
Table 3. Remicade Features
Table 4. Rituxan Features
Table 5. Enbrel Features
Table 6. Lantus Features
Table 7. Avastin Features
Table 8. Herceptin Features
Table 9. Others Features
Table 11. Global Biologic Drugs Market Share by Application: 2020 VS 2026
Table 12. Diabetes Case Studies
Table 13. Inflammation Case Studies
Table 14. Auto-Immune Diseases Case Studies
Table 15. Blood Diseases Case Studies
Table 16. Cardiovascular Diseases Case Studies
Table 17. Others Case Studies
Table 21. Commodity Prices-Metals Price Indices
Table 22. Commodity Prices- Precious Metal Price Indices
Table 23. Commodity Prices- Agricultural Raw Material Price Indices
Table 24. Commodity Prices- Food and Beverage Price Indices
Table 25. Commodity Prices- Fertilizer Price Indices
Table 26. Commodity Prices- Energy Price Indices
Table 27. G20+: Economic Policy Responses to COVID-19
Table 28. Biologic Drugs Report Years Considered
Table 29. Global Biologic Drugs Market Size YoY Growth 2021-2026 (US$ Million)
Table 30. Global Biologic Drugs Market Share by Regions: 2021 VS 2026
Table 31. North America Biologic Drugs Market Size YoY Growth (2015-2026) (US$ Million)
Table 32. East Asia Biologic Drugs Market Size YoY Growth (2015-2026) (US$ Million)
Table 33. Europe Biologic Drugs Market Size YoY Growth (2015-2026) (US$ Million)
Table 34. South Asia Biologic Drugs Market Size YoY Growth (2015-2026) (US$ Million)
Table 35. Southeast Asia Biologic Drugs Market Size YoY Growth (2015-2026) (US$ Million)
Table 36. Middle East Biologic Drugs Market Size YoY Growth (2015-2026) (US$ Million)
Table 37. Africa Biologic Drugs Market Size YoY Growth (2015-2026) (US$ Million)
Table 38. Oceania Biologic Drugs Market Size YoY Growth (2015-2026) (US$ Million)
Table 39. South America Biologic Drugs Market Size YoY Growth (2015-2026) (US$ Million)
Table 40. Rest of the World Biologic Drugs Market Size YoY Growth (2015-2026) (US$ Million)
Table 41. North America Biologic Drugs Consumption by Countries (2015-2020)
Table 42. East Asia Biologic Drugs Consumption by Countries (2015-2020)
Table 43. Europe Biologic Drugs Consumption by Region (2015-2020)
Table 44. South Asia Biologic Drugs Consumption by Countries (2015-2020)
Table 45. Southeast Asia Biologic Drugs Consumption by Countries (2015-2020)
Table 46. Middle East Biologic Drugs Consumption by Countries (2015-2020)
Table 47. Africa Biologic Drugs Consumption by Countries (2015-2020)
Table 48. Oceania Biologic Drugs Consumption by Countries (2015-2020)
Table 49. South America Biologic Drugs Consumption by Countries (2015-2020)
Table 50. Rest of the World Biologic Drugs Consumption by Countries (2015-2020)
Table 51. Roche Biologic Drugs Product Specification
Table 52. Novartis Biologic Drugs Product Specification
Table 53. Merck & Co. Biologic Drugs Product Specification
Table 54. Abbott Laboratories Biologic Drugs Product Specification
Table 55. Sanofi Biologic Drugs Product Specification
Table 56. Johnson & Johnson Biologic Drugs Product Specification
Table 57. Amgen Biologic Drugs Product Specification
Table 58. Amgen Biologic Drugs Product Specification
Table 59. Pfizer Biologic Drugs Product Specification
Table 60. Eli Lilly Biologic Drugs Product Specification
Table 101. Global Biologic Drugs Production Forecast by Region (2021-2026)
Table 102. Global Biologic Drugs Sales Volume Forecast by Type (2021-2026)
Table 103. Global Biologic Drugs Sales Volume Market Share Forecast by Type (2021-2026)
Table 104. Global Biologic Drugs Sales Revenue Forecast by Type (2021-2026)
Table 105. Global Biologic Drugs Sales Revenue Market Share Forecast by Type (2021-2026)
Table 106. Global Biologic Drugs Sales Price Forecast by Type (2021-2026)
Table 107. Global Biologic Drugs Consumption Volume Forecast by Application (2021-2026)
Table 108. Global Biologic Drugs Consumption Value Forecast by Application (2021-2026)
Table 109. North America Biologic Drugs Consumption Forecast 2021-2026 by Country
Table 110. East Asia Biologic Drugs Consumption Forecast 2021-2026 by Country
Table 111. Europe Biologic Drugs Consumption Forecast 2021-2026 by Country
Table 112. South Asia Biologic Drugs Consumption Forecast 2021-2026 by Country
Table 113. Southeast Asia Biologic Drugs Consumption Forecast 2021-2026 by Country
Table 114. Middle East Biologic Drugs Consumption Forecast 2021-2026 by Country
Table 115. Africa Biologic Drugs Consumption Forecast 2021-2026 by Country
Table 116. Oceania Biologic Drugs Consumption Forecast 2021-2026 by Country
Table 117. South America Biologic Drugs Consumption Forecast 2021-2026 by Country
Table 118. Rest of the world Biologic Drugs Consumption Forecast 2021-2026 by Country
Table 119. Biologic Drugs Distributors List
Table 120. Biologic Drugs Customers List
Table 121. Porter's Five Forces Analysis
Table 122. Key Executives Interviewed
Figure 1. North America Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 2. North America Biologic Drugs Consumption Market Share by Countries in 2020
Figure 3. United States Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 4. Canada Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 5. Mexico Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 6. East Asia Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 7. East Asia Biologic Drugs Consumption Market Share by Countries in 2020
Figure 8. China Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 9. Japan Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 10. South Korea Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 11. Europe Biologic Drugs Consumption and Growth Rate
Figure 12. Europe Biologic Drugs Consumption Market Share by Region in 2020
Figure 13. Germany Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 14. United Kingdom Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 15. France Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 16. Italy Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 17. Russia Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 18. Spain Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 19. Netherlands Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 20. Switzerland Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 21. Poland Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 22. South Asia Biologic Drugs Consumption and Growth Rate
Figure 23. South Asia Biologic Drugs Consumption Market Share by Countries in 2020
Figure 24. India Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 25. Pakistan Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 26. Bangladesh Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 27. Southeast Asia Biologic Drugs Consumption and Growth Rate
Figure 28. Southeast Asia Biologic Drugs Consumption Market Share by Countries in 2020
Figure 29. Indonesia Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 30. Thailand Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 31. Singapore Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 32. Malaysia Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 33. Philippines Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 34. Vietnam Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 35. Myanmar Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 36. Middle East Biologic Drugs Consumption and Growth Rate
Figure 37. Middle East Biologic Drugs Consumption Market Share by Countries in 2020
Figure 38. Turkey Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 39. Saudi Arabia Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 40. Iran Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 41. United Arab Emirates Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 42. Israel Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 43. Iraq Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 44. Qatar Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 45. Kuwait Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 46. Oman Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 47. Africa Biologic Drugs Consumption and Growth Rate
Figure 48. Africa Biologic Drugs Consumption Market Share by Countries in 2020
Figure 49. Nigeria Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 50. South Africa Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 51. Egypt Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 52. Algeria Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 53. Morocco Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 54. Oceania Biologic Drugs Consumption and Growth Rate
Figure 55. Oceania Biologic Drugs Consumption Market Share by Countries in 2020
Figure 56. Australia Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 57. New Zealand Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 58. South America Biologic Drugs Consumption and Growth Rate
Figure 59. South America Biologic Drugs Consumption Market Share by Countries in 2020
Figure 60. Brazil Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 61. Argentina Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 62. Columbia Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 63. Chile Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 64. Venezuelal Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 65. Peru Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 66. Puerto Rico Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 67. Ecuador Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 68. Rest of the World Biologic Drugs Consumption and Growth Rate
Figure 69. Rest of the World Biologic Drugs Consumption Market Share by Countries in 2020
Figure 70. Kazakhstan Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 71. Global Biologic Drugs Production Capacity Growth Rate Forecast (2021-2026)
Figure 72. Global Biologic Drugs Revenue Growth Rate Forecast (2021-2026)
Figure 73. Global Biologic Drugs Price and Trend Forecast (2015-2026)
Figure 74. North America Biologic Drugs Production Growth Rate Forecast (2021-2026)
Figure 75. North America Biologic Drugs Revenue Growth Rate Forecast (2021-2026)
Figure 76. East Asia Biologic Drugs Production Growth Rate Forecast (2021-2026)
Figure 77. East Asia Biologic Drugs Revenue Growth Rate Forecast (2021-2026)
Figure 78. Europe Biologic Drugs Production Growth Rate Forecast (2021-2026)
Figure 79. Europe Biologic Drugs Revenue Growth Rate Forecast (2021-2026)
Figure 80. South Asia Biologic Drugs Production Growth Rate Forecast (2021-2026)
Figure 81. South Asia Biologic Drugs Revenue Growth Rate Forecast (2021-2026)
Figure 82. Southeast Asia Biologic Drugs Production Growth Rate Forecast (2021-2026)
Figure 83. Southeast Asia Biologic Drugs Revenue Growth Rate Forecast (2021-2026)
Figure 84. Middle East Biologic Drugs Production Growth Rate Forecast (2021-2026)
Figure 85. Middle East Biologic Drugs Revenue Growth Rate Forecast (2021-2026)
Figure 86. Africa Biologic Drugs Production Growth Rate Forecast (2021-2026)
Figure 87. Africa Biologic Drugs Revenue Growth Rate Forecast (2021-2026)
Figure 88. Oceania Biologic Drugs Production Growth Rate Forecast (2021-2026)
Figure 89. Oceania Biologic Drugs Revenue Growth Rate Forecast (2021-2026)
Figure 90. South America Biologic Drugs Production Growth Rate Forecast (2021-2026)
Figure 91. South America Biologic Drugs Revenue Growth Rate Forecast (2021-2026)
Figure 92. Rest of the World Biologic Drugs Production Growth Rate Forecast (2021-2026)
Figure 93. Rest of the World Biologic Drugs Revenue Growth Rate Forecast (2021-2026)
Figure 94. North America Biologic Drugs Consumption Forecast 2021-2026
Figure 95. East Asia Biologic Drugs Consumption Forecast 2021-2026
Figure 96. Europe Biologic Drugs Consumption Forecast 2021-2026
Figure 97. South Asia Biologic Drugs Consumption Forecast 2021-2026
Figure 98. Southeast Asia Biologic Drugs Consumption Forecast 2021-2026
Figure 99. Middle East Biologic Drugs Consumption Forecast 2021-2026
Figure 100. Africa Biologic Drugs Consumption Forecast 2021-2026
Figure 101. Oceania Biologic Drugs Consumption Forecast 2021-2026
Figure 102. South America Biologic Drugs Consumption Forecast 2021-2026
Figure 103. Rest of the world Biologic Drugs Consumption Forecast 2021-2026
Figure 104. Channels of Distribution
Figure 105. Distributors Profiles
Table 1. Global Biologic Drugs Market Share by Type: 2020 VS 2026
Table 2. Humira Features
Table 3. Remicade Features
Table 4. Rituxan Features
Table 5. Enbrel Features
Table 6. Lantus Features
Table 7. Avastin Features
Table 8. Herceptin Features
Table 9. Others Features
Table 11. Global Biologic Drugs Market Share by Application: 2020 VS 2026
Table 12. Diabetes Case Studies
Table 13. Inflammation Case Studies
Table 14. Auto-Immune Diseases Case Studies
Table 15. Blood Diseases Case Studies
Table 16. Cardiovascular Diseases Case Studies
Table 17. Others Case Studies
Table 21. Commodity Prices-Metals Price Indices
Table 22. Commodity Prices- Precious Metal Price Indices
Table 23. Commodity Prices- Agricultural Raw Material Price Indices
Table 24. Commodity Prices- Food and Beverage Price Indices
Table 25. Commodity Prices- Fertilizer Price Indices
Table 26. Commodity Prices- Energy Price Indices
Table 27. G20+: Economic Policy Responses to COVID-19
Table 28. Biologic Drugs Report Years Considered
Table 29. Global Biologic Drugs Market Size YoY Growth 2021-2026 (US$ Million)
Table 30. Global Biologic Drugs Market Share by Regions: 2021 VS 2026
Table 31. North America Biologic Drugs Market Size YoY Growth (2015-2026) (US$ Million)
Table 32. East Asia Biologic Drugs Market Size YoY Growth (2015-2026) (US$ Million)
Table 33. Europe Biologic Drugs Market Size YoY Growth (2015-2026) (US$ Million)
Table 34. South Asia Biologic Drugs Market Size YoY Growth (2015-2026) (US$ Million)
Table 35. Southeast Asia Biologic Drugs Market Size YoY Growth (2015-2026) (US$ Million)
Table 36. Middle East Biologic Drugs Market Size YoY Growth (2015-2026) (US$ Million)
Table 37. Africa Biologic Drugs Market Size YoY Growth (2015-2026) (US$ Million)
Table 38. Oceania Biologic Drugs Market Size YoY Growth (2015-2026) (US$ Million)
Table 39. South America Biologic Drugs Market Size YoY Growth (2015-2026) (US$ Million)
Table 40. Rest of the World Biologic Drugs Market Size YoY Growth (2015-2026) (US$ Million)
Table 41. North America Biologic Drugs Consumption by Countries (2015-2020)
Table 42. East Asia Biologic Drugs Consumption by Countries (2015-2020)
Table 43. Europe Biologic Drugs Consumption by Region (2015-2020)
Table 44. South Asia Biologic Drugs Consumption by Countries (2015-2020)
Table 45. Southeast Asia Biologic Drugs Consumption by Countries (2015-2020)
Table 46. Middle East Biologic Drugs Consumption by Countries (2015-2020)
Table 47. Africa Biologic Drugs Consumption by Countries (2015-2020)
Table 48. Oceania Biologic Drugs Consumption by Countries (2015-2020)
Table 49. South America Biologic Drugs Consumption by Countries (2015-2020)
Table 50. Rest of the World Biologic Drugs Consumption by Countries (2015-2020)
Table 51. Roche Biologic Drugs Product Specification
Table 52. Novartis Biologic Drugs Product Specification
Table 53. Merck & Co. Biologic Drugs Product Specification
Table 54. Abbott Laboratories Biologic Drugs Product Specification
Table 55. Sanofi Biologic Drugs Product Specification
Table 56. Johnson & Johnson Biologic Drugs Product Specification
Table 57. Amgen Biologic Drugs Product Specification
Table 58. Amgen Biologic Drugs Product Specification
Table 59. Pfizer Biologic Drugs Product Specification
Table 60. Eli Lilly Biologic Drugs Product Specification
Table 101. Global Biologic Drugs Production Forecast by Region (2021-2026)
Table 102. Global Biologic Drugs Sales Volume Forecast by Type (2021-2026)
Table 103. Global Biologic Drugs Sales Volume Market Share Forecast by Type (2021-2026)
Table 104. Global Biologic Drugs Sales Revenue Forecast by Type (2021-2026)
Table 105. Global Biologic Drugs Sales Revenue Market Share Forecast by Type (2021-2026)
Table 106. Global Biologic Drugs Sales Price Forecast by Type (2021-2026)
Table 107. Global Biologic Drugs Consumption Volume Forecast by Application (2021-2026)
Table 108. Global Biologic Drugs Consumption Value Forecast by Application (2021-2026)
Table 109. North America Biologic Drugs Consumption Forecast 2021-2026 by Country
Table 110. East Asia Biologic Drugs Consumption Forecast 2021-2026 by Country
Table 111. Europe Biologic Drugs Consumption Forecast 2021-2026 by Country
Table 112. South Asia Biologic Drugs Consumption Forecast 2021-2026 by Country
Table 113. Southeast Asia Biologic Drugs Consumption Forecast 2021-2026 by Country
Table 114. Middle East Biologic Drugs Consumption Forecast 2021-2026 by Country
Table 115. Africa Biologic Drugs Consumption Forecast 2021-2026 by Country
Table 116. Oceania Biologic Drugs Consumption Forecast 2021-2026 by Country
Table 117. South America Biologic Drugs Consumption Forecast 2021-2026 by Country
Table 118. Rest of the world Biologic Drugs Consumption Forecast 2021-2026 by Country
Table 119. Biologic Drugs Distributors List
Table 120. Biologic Drugs Customers List
Table 121. Porter's Five Forces Analysis
Table 122. Key Executives Interviewed
Figure 1. North America Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 2. North America Biologic Drugs Consumption Market Share by Countries in 2020
Figure 3. United States Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 4. Canada Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 5. Mexico Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 6. East Asia Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 7. East Asia Biologic Drugs Consumption Market Share by Countries in 2020
Figure 8. China Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 9. Japan Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 10. South Korea Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 11. Europe Biologic Drugs Consumption and Growth Rate
Figure 12. Europe Biologic Drugs Consumption Market Share by Region in 2020
Figure 13. Germany Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 14. United Kingdom Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 15. France Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 16. Italy Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 17. Russia Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 18. Spain Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 19. Netherlands Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 20. Switzerland Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 21. Poland Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 22. South Asia Biologic Drugs Consumption and Growth Rate
Figure 23. South Asia Biologic Drugs Consumption Market Share by Countries in 2020
Figure 24. India Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 25. Pakistan Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 26. Bangladesh Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 27. Southeast Asia Biologic Drugs Consumption and Growth Rate
Figure 28. Southeast Asia Biologic Drugs Consumption Market Share by Countries in 2020
Figure 29. Indonesia Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 30. Thailand Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 31. Singapore Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 32. Malaysia Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 33. Philippines Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 34. Vietnam Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 35. Myanmar Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 36. Middle East Biologic Drugs Consumption and Growth Rate
Figure 37. Middle East Biologic Drugs Consumption Market Share by Countries in 2020
Figure 38. Turkey Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 39. Saudi Arabia Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 40. Iran Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 41. United Arab Emirates Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 42. Israel Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 43. Iraq Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 44. Qatar Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 45. Kuwait Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 46. Oman Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 47. Africa Biologic Drugs Consumption and Growth Rate
Figure 48. Africa Biologic Drugs Consumption Market Share by Countries in 2020
Figure 49. Nigeria Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 50. South Africa Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 51. Egypt Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 52. Algeria Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 53. Morocco Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 54. Oceania Biologic Drugs Consumption and Growth Rate
Figure 55. Oceania Biologic Drugs Consumption Market Share by Countries in 2020
Figure 56. Australia Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 57. New Zealand Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 58. South America Biologic Drugs Consumption and Growth Rate
Figure 59. South America Biologic Drugs Consumption Market Share by Countries in 2020
Figure 60. Brazil Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 61. Argentina Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 62. Columbia Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 63. Chile Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 64. Venezuelal Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 65. Peru Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 66. Puerto Rico Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 67. Ecuador Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 68. Rest of the World Biologic Drugs Consumption and Growth Rate
Figure 69. Rest of the World Biologic Drugs Consumption Market Share by Countries in 2020
Figure 70. Kazakhstan Biologic Drugs Consumption and Growth Rate (2015-2020)
Figure 71. Global Biologic Drugs Production Capacity Growth Rate Forecast (2021-2026)
Figure 72. Global Biologic Drugs Revenue Growth Rate Forecast (2021-2026)
Figure 73. Global Biologic Drugs Price and Trend Forecast (2015-2026)
Figure 74. North America Biologic Drugs Production Growth Rate Forecast (2021-2026)
Figure 75. North America Biologic Drugs Revenue Growth Rate Forecast (2021-2026)
Figure 76. East Asia Biologic Drugs Production Growth Rate Forecast (2021-2026)
Figure 77. East Asia Biologic Drugs Revenue Growth Rate Forecast (2021-2026)
Figure 78. Europe Biologic Drugs Production Growth Rate Forecast (2021-2026)
Figure 79. Europe Biologic Drugs Revenue Growth Rate Forecast (2021-2026)
Figure 80. South Asia Biologic Drugs Production Growth Rate Forecast (2021-2026)
Figure 81. South Asia Biologic Drugs Revenue Growth Rate Forecast (2021-2026)
Figure 82. Southeast Asia Biologic Drugs Production Growth Rate Forecast (2021-2026)
Figure 83. Southeast Asia Biologic Drugs Revenue Growth Rate Forecast (2021-2026)
Figure 84. Middle East Biologic Drugs Production Growth Rate Forecast (2021-2026)
Figure 85. Middle East Biologic Drugs Revenue Growth Rate Forecast (2021-2026)
Figure 86. Africa Biologic Drugs Production Growth Rate Forecast (2021-2026)
Figure 87. Africa Biologic Drugs Revenue Growth Rate Forecast (2021-2026)
Figure 88. Oceania Biologic Drugs Production Growth Rate Forecast (2021-2026)
Figure 89. Oceania Biologic Drugs Revenue Growth Rate Forecast (2021-2026)
Figure 90. South America Biologic Drugs Production Growth Rate Forecast (2021-2026)
Figure 91. South America Biologic Drugs Revenue Growth Rate Forecast (2021-2026)
Figure 92. Rest of the World Biologic Drugs Production Growth Rate Forecast (2021-2026)
Figure 93. Rest of the World Biologic Drugs Revenue Growth Rate Forecast (2021-2026)
Figure 94. North America Biologic Drugs Consumption Forecast 2021-2026
Figure 95. East Asia Biologic Drugs Consumption Forecast 2021-2026
Figure 96. Europe Biologic Drugs Consumption Forecast 2021-2026
Figure 97. South Asia Biologic Drugs Consumption Forecast 2021-2026
Figure 98. Southeast Asia Biologic Drugs Consumption Forecast 2021-2026
Figure 99. Middle East Biologic Drugs Consumption Forecast 2021-2026
Figure 100. Africa Biologic Drugs Consumption Forecast 2021-2026
Figure 101. Oceania Biologic Drugs Consumption Forecast 2021-2026
Figure 102. South America Biologic Drugs Consumption Forecast 2021-2026
Figure 103. Rest of the world Biologic Drugs Consumption Forecast 2021-2026
Figure 104. Channels of Distribution
Figure 105. Distributors Profiles
